Trump’s Covid-19 Drug to Get More Scrutiny in 40,000-Person Test

(Bloomberg) -- The antimalarial drug that U.S. President Donald Trump touted for Covid-19 is getting another chance, as a global clinical trial will try to determine the treatment’s effectiveness i...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.